New IPO filings include BridgeBio, Dermavant, Prevail, Atreca, Akero

In a week in which two biotechs went public and a third opted for a billion-dollar takeout instead of an IPO, five companies filed on Friday to list on NASDAQ in IPOs that could raise a total of $611.3 million. The group includes BridgeBio, Dermavant, Prevail, Atreca and Akero.